RETRACTED ARTICLE: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study-Reference-Cited by-同舟云学术

RETRACTED ARTICLE: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study

Published:2016-12-13 Issue:4 Volume:25 Page:1279-1289
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Hansen Per Boye^ORCID,Penkowa Milena

Funder

Herlev Hospital

Lægeforeningens Forskningsfond

Mimi og Viktor Larsens Fond

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-016-3522-6.pdf

Reference31 articles.

1. Attal M, Harousseau JL, Stoppa AM et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. N Engl J Med 335:91–97

2. Child JA, Morgan GJ, Davies FE et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348:1875–1883

3. Fernandes LL, Torres SR, Garnica M et al (2014) Oral status of patients submitted to autologous hematopoietic stem cell transplantation. Support Care Cancer 22:15–21

4. Wardill HR, Bowen JM, Gibson RJ (2014) New pharmacotherapy options for chemotherapy-induced alimentary mucositis. Expert Opin Biol Ther 14:347–354

5. Waśko-Grabowska A, Rzepecki P, Oborska S et al (2011) Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc 43:3111–3113

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults;Advances in Therapy;2021-03-18

2. Is There a Role for Bismuth in Diarrhea Management?;Rambam Maimonides Medical Journal;2021-01-19

3. Retraction Note to: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study;Supportive Care in Cancer;2020-10-06

4. Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses;Supportive Care in Cancer;2017-08-29